| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/26/2013 | US8383650 Organic compounds |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/21/2013 | WO2013025984A2 Cannabinoid receptor treatments |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024164A1 Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | WO2013006050A9 Peptides inducing or enhancing an immune response against prostate-specific membrane protein (psma) |
| 02/21/2013 | WO2013002485A3 Pharmaceutical composition for preventing and treating kidney disorders, containing inhibitor for phosphorylation of taz tyrosine as active ingredient for activation of nfat5/tonebp |
| 02/21/2013 | WO2012170931A3 Compounds that modulate intracellular calcium |
| 02/21/2013 | WO2012022120A8 Dihydropyrazole compounds |
| 02/21/2013 | US20130046275 Material and method for treating internal cavities |
| 02/21/2013 | US20130046026 Composition with improved skin penetration for transdermal delivery of tolterodine |
| 02/21/2013 | US20130046025 Composition with low skin irritation for transdermal delivery of tolterodine |
| 02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045988 Combination therapy |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045966 Method of Lowering Serum Uric Acid Levels With (S)-Tofisopam |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045919 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | US20130045213 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity |
| 02/21/2013 | US20130045194 Delivery of Cholesteryl Ester to Steroidogenic Tissues |
| 02/21/2013 | CA2845516A1 Muscle tissue regeneration using muscle fiber fragments |
| 02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
| 02/21/2013 | CA2845039A1 Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/20/2013 | EP2559439A1 Pharmaceutical preparation for treating benign prostatic hyperplasia |
| 02/20/2013 | EP2558455A1 Synthesis of duloxetine and/or pharmaceutically acceptable salts thereof |
| 02/20/2013 | EP2558083A1 Methods for providing enhanced resveratrol activity using 4-acetoxy-resveratrol |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102935214A Traditional Chinese medicinal composition for treating uremia |
| 02/20/2013 | CN102935203A Chinese medicament for treating nephritis |
| 02/20/2013 | CN102935095A Bidirectional solid fermentation irpex cacteus mycoplasm extractive and preparation method and application thereof |
| 02/20/2013 | CN102406762B Chinese medicinal preparation for treating chronic prostatitis |
| 02/20/2013 | CN102114163B Traditional Chinese medicine for treating Henoch-Schonlein purpura nephritis |
| 02/20/2013 | CN101700265B Application of notoginseng and extract thereof in preparing medicament for curing and/or preventing diabetic microangiopathies |
| 02/20/2013 | CN101658599B Method for analyzing prostate jindan capsules |
| 02/19/2013 | US8377968 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377886 Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease |
| 02/19/2013 | US8377880 Therapeutic agents for reducing parathyroid hormone levels |
| 02/19/2013 | US8377878 Therapies for chronic renal failure |
| 02/19/2013 | US8377428 Low salt forms of polyallylamine |
| 02/14/2013 | WO2013021276A1 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 02/14/2013 | WO2013020243A1 Pharmaceutical composition containing insoluble medicine |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130041000 Novel azole compound |
| 02/14/2013 | US20130040994 Methods of Treatment Using Allosteric Processing Inhibitors for Matrix Metalloproteinases |
| 02/14/2013 | US20130040975 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2013 | US20130040957 Deuterium-Enriched Pyrimidine Compounds and Derivatives |
| 02/14/2013 | US20130040917 Phenazopyridine Compounds |
| 02/14/2013 | US20130040916 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040881 Ltbp2 as a biomarker for renal dysfunction |
| 02/14/2013 | US20130039993 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures |
| 02/14/2013 | US20130039983 Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects |
| 02/14/2013 | US20130039978 Medicinal compositions and method for treatment of urinary tract infections |
| 02/14/2013 | US20130039923 Anti-human interleukin-20 antibodies |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039897 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 02/13/2013 | CN102933559A Optically active dibenzylamine derivative, and manufacturing method for same |
| 02/13/2013 | CN102933548A Carboxamide compounds and their use as calpain inhibitors |
| 02/13/2013 | CN102933233A Agent for treating renal fibrosis |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102924303A Tapentadol hydrochloride crystal form C, and preparation method and application thereof |
| 02/13/2013 | CN102920999A Application of Chinese yarn glycoprotein in preparation of medicament for treating nephritis and renal hypertension |
| 02/13/2013 | CN102920991A Application of composition of Chinese yarn polysaccharide and Chinese yarn protein |
| 02/13/2013 | CN102920981A Traditional Chinese medicine for treating hepatorenal syndrome |
| 02/13/2013 | CN102920950A Traditional Chinese medicine preparation for curing gonococcal urethritis |
| 02/13/2013 | CN102920884A Traditional Chinese medicine (TCM) for curing chronic prostatitis |
| 02/13/2013 | CN102920856A Nine-ingredient stranguria-treating toxin-vanquishing decoction |
| 02/13/2013 | CN102920833A Externally applied medicine for curing prostatitis |
| 02/13/2013 | CN102920802A Foot bath prescription for home health care |
| 02/13/2013 | CN102920778A Mesona chinensis harvesting and primary processing method |
| 02/13/2013 | CN102920751A Turpinia arguta leaf total flavonoid ethanol reflux extract, preparation method and uses thereof |
| 02/13/2013 | CN102920695A Benzofuran endothelin receptor antagonist and use |
| 02/13/2013 | CN102919829A Ganoderma lucidum product, as well as preparation method, application and using method thereof |
| 02/13/2013 | CN102600219B Total flavone extract of abelmoschus manihot and preparing method of total flavone extract |
| 02/13/2013 | CN102274406B Chinese medicinal composition for treating kidney stone |
| 02/13/2013 | CN102212446B Physical strength strengthening health-care medicinal liquor capable of tonifying kidney, strengthening yang and enhancing immunity and preparation method thereof |
| 02/13/2013 | CN102106978B Medicament for treating nephritis |
| 02/13/2013 | CN102048770B Artificially-cultured cordceps militaris sporocarp extract and preparation process thereof |
| 02/13/2013 | CN101918364B Composition and method for treating proteinuria |
| 02/13/2013 | CN101804090B Tablet used for treating prostate diseases as well as preparation method and application thereof |
| 02/13/2013 | CN101721468B Method for preparing salvianolic acids |
| 02/12/2013 | US8372404 Anti-C5/C5a antibodies and methods of use |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | CA2596527C Igf-1r inhibitors |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 02/12/2013 | CA2359650C Pharmaceutical preparations and methods for inhibiting tumors |
| 02/07/2013 | WO2013018883A1 Cancer treatment and/or prevention drug composition |
| 02/07/2013 | WO2013018837A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |